Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Splice-switching oligonucleotide induces RNA repair in model of beta-thalassemia

Jan. 26, 2009

Joslin to initiate clinical trial of antiinflammatory salsalate in type 2 diabetes

Jan. 26, 2009

GlaxoSmithKline receives European approval to market orlistat 60 mg

Jan. 23, 2009

New cathepsin K inhibitors for treating osteoporosis imparted by AstraZeneca

Jan. 23, 2009

Recalbon/Bonoteo tablets approved in Japan for osteoporosis treatment

Jan. 22, 2009

3SBio files for approval in China for TPIAO label extension in ITP

Jan. 22, 2009

Ablynx transfers in-house bone disorder R&D program with Procter & Gamble

Jan. 22, 2009

Obecure completes enrollment in confirmatory phase IIb Histalean trial

Jan. 21, 2009

Pfizer receives FDA complete response letter for lasofoxifene in osteoporosis

Jan. 20, 2009

FDA unable to complete review of Takeda's NDA for febuxostat by January 2009

Jan. 20, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...